1. Ferrero-Miliani L, Nielsen OH, Andersen PS, Girardin SE. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1β generation. Clin Exp Immunol. 2007. 147:227–235.
Article
2. Frostegård J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, Hansson GK. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis. 1999. 145:33–43.
Article
3. Jara LJ, Medina G, Vera-Lastra O, Amigo MC. Accelerated atherosclerosis, immune response and autoimmune rheumatic diseases. Autoimmun Rev. 2006. 5:195–201.
Article
4. Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell. 2006. 124:823–835.
Article
5. Sarkar D, Fisher PB. Molecular mechanisms of aging-associated inflammation. Cancer Lett. 2006. 236:13–23.
Article
6. Walsh LJ. Mast cells and oral inflammation. Crit Rev Oral Biol Med. 2003. 14:188–198.
Article
7. Fujiwara N, Kobayashi K. Macrophages in inflammation. Curr Drug Targets Inflamm Allergy. 2005. 4:281–286.
Article
8. Nicholas C, Batra S, Vargo MA, Voss OH, Gavrilin MA, Wewers MD, Guttridge DC, Grotewold E, Doseff AI. Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-κB through the suppression of p65 phosphorylation. J Immunol. 2007. 179:7121–7127.
Article
9. Hortelano S, Zeini M, Boscá L. Nitric oxide and resolution of inflammation. Methods Enzymol. 2002. 359:459–465.
Article
10. Sacco RE, Waters WR, Rudolph KM, Drew ML. Comparative nitric oxide production by LPS-stimulated monocyte-derived macrophages from
Ovis canadensis and
Ovis aries. Comp Immunol Microbiol Infect Dis. 2006. 29:1–11.
Article
11. Farley KS, Wang LF, Razavi HM, Law C, Rohan M, McCormack DG, Mehta S. Effects of macrophage inducible nitric oxide synthase in murine septic lung injury. Am J Physiol Lung Cell Mol Physiol. 2006. 290:L1164–L1172.
Article
12. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A. 1993. 90:7240–7244.
Article
13. Yoon WJ, Ham YM, Kim KN, Park SY, Lee NH, Hyun CG, Lee WJ. Anti-inflammatory activity of brown alga Dictyota dichotoma in murine macrophage RAW 264.7 cells. J Med Plant Res. 2009. 3:1–8.
14. Neels JG, Olefsky JM. Inflamed fat: what starts the fire? J Clin Invest. 2006. 116:33–35.
Article
15. Pryor WA. The antioxidant nutrients and disease prevention-what do we know and what do we need to find out? Am J Clin Nutr. 1991. 53:391S–393S.
Article
16. Rigelsky JM, Sweet BV. Hawthorn: pharmacology and therapeutic uses. Am J Health Syst Pharm. 2002. 59:417–422.
Article
17. Zhang Z, Ho WKK, Huang Y, James AE, Lam LW, Chen ZY. Hawthorn fruit is hypolipidemic in rabbits fed a high cholesterol diet. J Nutr. 2002. 132:5–10.
Article
18. Froehlicher T, Hennebelle T, Martin-Nizard F, Cleenewerck P, Hilbert JL, Trotin F, Grec S. Phenolic profiles and antioxidative effects of hawthorn cell suspensions, fresh fruits, and medicinal dried parts. Food Chem. 2009. 115:897–903.
Article
19. Kim KM, Choi JY, Yoo SE, Park MY, Lee BS, Ko TH, Sung SH, Shin HM, Park JE. HMCO5, herbal extract, inhibits NF-κB expression in lipopolysaccharide treated macrophages and reduces atherosclerotic lesions in cholesterol fed mice. J Ethnopharmacol. 2007. 114:316–324.
Article
20. Ko SH, Choi SW, Ye SK, Yoo S, Kim HS, Chung MH. Comparison of anti-oxidant activities of seventy herbs that have been used in Korean traditional medicine. Nutr Res Pract. 2008. 2:143–151.
Article
21. Park JH, Li C, Hu W, Wang MH. Antioxidant and free radical scavenging activity of different fractions from hawthorn fruit. J Food Sci Nutr. 2010. 15:44–50.
Article
22. Li C, Son HJ, Huang C, Lee SK, Lohakare J, Wang MH. Comparison of
Crataegus pinnatifida Bunge var.
typica Schneider and
C. pinnatifida Bunge fruits for antioxidant, anti-α-glucosidase, and anti-inflammatory activities. Food Sci Biotechnol. 2010. 19:769–775.
Article
23. Sherman MP, Aeberhard EE, Wong VZ, Griscavage JM, Ignarro LJ. Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. Biochem Biophys Res Commun. 1993. 191:1301–1308.
Article
24. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol. 1997. 15:323–350.
Article
25. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996. 271:C1424–C1437.
Article
26. Li XA, Guo L, Asmis R, Nikolova-Karakashian M, Smart EJ. Scavenger receptor BI prevents nitric oxide-induced cytotoxicity and endotoxin-induced death. Circ Res. 2006. 98:e60–e65.
Article
27. Jayakumar T, Thomas PA, Geraldine P.
In-vitro antioxidant activities of an ethanolic extract of the oyster mushroom, Pleurotus ostreatus. IFSET. 2009. 10:228–234.
Article
28. Boscá L, Zeini M, Través PG, Hortelano S. Nitric oxide and cell viability in inflammatory cells: a role for NO in macrophage function and fate. Toxicology. 2005. 208:249–258.
Article
29. Sarkar D, Saha P, Gamre S, Bhattacharjee S, Hariharan C, Ganguly S, Sen R, Mandal G, Chattopadhyay S, Majumdar S, Chatterjee M. Anti-inflammatory effect of allylpyrocatechol in LPS-induced macrophages is mediated by suppression of iNOS and COX-2 via the NF-κB pathway. Int Immunopharmacol. 2008. 8:1264–1271.
Article
30. Hori M, Kita M, Torihashi S, Miyamoto S, Won KJ, Sato K, Ozaki H, Karaki H. Upregulation of iNOS by COX-2 in muscularis resident macrophage of rat intestine stimulated with LPS. Am J Physiol Gastrointest Liver Physiol. 2001. 280:G930–G938.
Article
31. Li C, Han W, Wang MH. Antioxidant activity of hawthorn fruit in vitro. J Appl Biol Chem. 2010. 53:8–12.
32. Perkins DJ, Kniss DA. Blockade of nitric oxide formation down-regulates cyclooxygenase-2 and decreases PGE2 biosynthesis in macrophages. J Leukoc Biol. 1999. 65:792–799.
Article
33. Tsatsanis C, Androulidaki A, Venihaki M, Margioris AN. Signalling networks regulating cyclooxygenase-2. Int J Biochem Cell Biol. 2006. 38:1654–1661.
Article
34. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP. Tumor necrosis factor receptor and Fas signaling mechanisms. Ann Rev Immunol. 1999. 17:331–367.
Article
35. Aggarwal BB, Natarajan K. Tumor necrosis factors: developments during the last decade. Eur Cytokine Netw. 1996. 7:93–124.
36. Kim JY, Park SJ, Yun KJ, Cho YW, Park HJ, Lee KT. Isoliquiritigenin isolated from the roots of
Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression
via the attenuation of NF-kB in RAW264.7 macrophages. Eur J Pharmacol. 2008. 584:175–184.
Article
37. Jung WK, Choi I, Lee DY, Yea SS, Choi YH, Kim MM, Park SG, Seo SK, Lee SW, Lee CM, Park YM, Choi IW. Caffeic acid phenethyl ester protects mice from lethal endotoxin shock and inhibits lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW 264.7 macrophages via the p38/ERK and NF-kB pathways. Int J Biochem Cell Biol. 2008. 40:2572–2582.
Article
38. Cheenpracha S, Park EJ, Yoshida WY, Barit C, Wall M, Pezzuto JM, Chang LC. Potential anti-inflammatory phenolic glycosides from the medicinal plant
Moringa oleifera fruits. Bioorg Med Chem. 2010. 18:6598–6602.
Article
39. Mueller M, Hobiger S, Jungbauer A. Anti-inflammatory activity of extracts from fruits, herbs and spices. Food Chem. 2010. 122:987–999.
Article